Videos
Press Releases

22 Sep 2022
EORTC Quality of Life Group celebrating 40 years

31 Aug 2022
EORTC Item Library provides considerable coverage of CTCAE side effects, new study finds

27 Jun 2022
PRESS RELEASE: Better treatment for better health: lifting the veil on treatment optimisation

17 Mar 2022
MSD’s KEYTRUDA® (pembrolizumab) Significantly Improved Disease-Free Survival (DFS) Versus Placebo as Adjuvant Therapy in Patients With Stage IB-IIIA Non-Small Cell Lung Cancer (NSCLC) Regardless of PD-L1 Expression
Latest Newsletter
News

4 Aug 2025
2148 MRD Study reaches milestone with First Patient In (FPI)

1 Jul 2025
PET imaging widely used in European brain tumour centres, survey shows

27 Jun 2025
New EORTC Leadership: President-Elect and Scientific Chairs Council

10 Jun 2025
First Site Activated in EU-Funded DE-ESCALATE Clinical Trial on Advanced Metastatic Prostate Cancer

4 Jun 2025
EORTC publishes its 2024 Annual Report: Driving progress in cancer treatment, together

4 Jun 2025
EORTC in the spotlight at ASCO 2025

28 May 2025
EORTC’s presence at ASCO 2025

20 May 2025
Celebrating Clinical Trials Day 2025 with EORTC’s Young and Early Career Investigators

19 May 2025
New commentary urges a rethink of quality of life metrics in cancer care economics in the context of EU HTA reform

14 May 2025
EORTC Quality of Life Conference 2025 wraps with strong call for patient-centred innovation in oncology

